Latest filing published 03 Oct 2013 for ONYX PHARMACEUTICALS INC, €598k.
No signal scores available.
Filings by Suzanne M. Shema span 2 companies, the busiest being Onyx Pharmaceuticals Inc and Zymogenetics Inc. We count 145 filings; the first trade dates from 14 March 2006 and the latest from 1 October 2013.
Every open-market trade on record is a sale: 64 sales worth €8.8M. The rest of the record consists of 10 share grants and 67 option exercises. In 2013 alone, the filings show no purchases and 18 sales.
The record was last updated on 3 October 2013 with a transaction (€2.6M) in Onyx Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 145 declarations